90 related articles for article (PubMed ID: 3395400)
1. Tissue distribution of the novel antitussive compound vadocaine hydrochloride in white female mice studied by whole-body autoradiography.
Vuorela A; Mäntylä R; Männistö PT
Arzneimittelforschung; 1988 Apr; 38(4A):628-30. PubMed ID: 3395400
[TBL] [Abstract][Full Text] [Related]
2. Preliminary pharmacokinetics of the new antitussive compound vadocaine hydrochloride in animals.
Mäntylä R; Männistö PT; Vuorela A; Nissinen E
Arzneimittelforschung; 1988 Apr; 38(4A):624-7. PubMed ID: 3395399
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of graded single doses of the novel antitussive compound vadocaine hydrochloride in healthy male volunteers.
Karttunen P; Männistö PT; Tukiainen H; Uusitupa M; Nissinen E
Arzneimittelforschung; 1988 Apr; 38(4A):635-8. PubMed ID: 3395402
[TBL] [Abstract][Full Text] [Related]
4. Studies on the nonspecific central nervous system effects of the novel antitussive compound vadocaine hydrochloride.
Karttunen P; Männistö PT; Lahovaara S; Havas A
Arzneimittelforschung; 1988 Apr; 38(4A):605-8. PubMed ID: 3395395
[TBL] [Abstract][Full Text] [Related]
5. Comparative studies on the dependence liability of morphine hydrochloride, codeine phosphate and two novel antitussive compounds vadocaine hydrochloride and N-(2',4'-dimethyl-6'-methoxyphenyl)-4-(diethylamine) butanamide hydrochloride in mice.
Etemadzadeh E; Ahtee L; Männistö PT
Arzneimittelforschung; 1988 Apr; 38(4A):620-3. PubMed ID: 3395398
[TBL] [Abstract][Full Text] [Related]
6. Steady state pharmacokinetics of the new antitussive compound vadocaine hydrochloride.
Silvasti M; Karttunen P; Tukiainen H; Mykkänen M; Ottoila P
Arzneimittelforschung; 1990 Apr; 40(4):453-6. PubMed ID: 2357246
[TBL] [Abstract][Full Text] [Related]
7. Antitussive action of the new anilide derivative vadocaine hydrochloride compared with codeine phosphate in four animal models.
Männistö PT; Karttunen P; Lahovaara S; Nissinen E; Davies JE; Algate DR; Baines MW
Arzneimittelforschung; 1988 Apr; 38(4A):598-604. PubMed ID: 3395394
[TBL] [Abstract][Full Text] [Related]
8. The single dose and steady-state pharmacokinetics of a vadocaine tablet in healthy human volunteers.
Silvasti M; Karttunen P; Tukiainen H; Mykkänen M; Hänninen U; Välttilä S
Int J Clin Pharmacol Ther Toxicol; 1989 Nov; 27(11):558-63. PubMed ID: 2613390
[TBL] [Abstract][Full Text] [Related]
9. First human studies on the safety and antitussive activity of vadocaine hydrochloride.
Karttunen P; Tukiainen H; Uusitupa M; Männistö PT
Arzneimittelforschung; 1988 Apr; 38(4A):631-4. PubMed ID: 3395401
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the safety margin of vadocaine hydrochloride in man.
Karttunen P; Uusitupa M; Helin M; Tukiainen H; Silvasti M
Arzneimittelforschung; 1988 Apr; 38(4A):642-6. PubMed ID: 3395404
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the antitussive effect of vadocaine hydrochloride using citric acid-induced cough in healthy volunteers.
Karttunen P
Arzneimittelforschung; 1988 Apr; 38(4A):639-41. PubMed ID: 3395403
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and ventilator effects of vadocaine hydrochloride in urethane-anaesthetized rats and guinea-pigs.
Paakkari I; Svartström-Fraser M
Arzneimittelforschung; 1988 Apr; 38(4A):617-9. PubMed ID: 3395397
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of two opioid antitussives, vadocaine hydrochloride, clobutinol and lidocaine on lung mechanics in guinea-pigs.
Salonen RO
Arzneimittelforschung; 1988 Apr; 38(4A):609-12. PubMed ID: 3395396
[TBL] [Abstract][Full Text] [Related]
14. Distribution and elimination of RGH-5002 in rats.
Terjéki E; Pátfalusi M; Trafikánt G; Kapás M
Acta Physiol Hung; 1995; 83(2):143-50. PubMed ID: 8588501
[TBL] [Abstract][Full Text] [Related]
15. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
[TBL] [Abstract][Full Text] [Related]
16. Vadocaine hydrochloride. A novel antitussive compound.
Arzneimittelforschung; 1988 Apr; 38(4A):597-646. PubMed ID: 3395393
[No Abstract] [Full Text] [Related]
17. Whole body distribution of the quaternary ammonium compound thiazinamium (N-methylpromethazine) and promethazine in monkey and mice.
Jonkman JH; Westenberg HG; Rijntjes NV; van der Kleijn E; Lindeboom SF
Arzneimittelforschung; 1983; 33(2):223-8. PubMed ID: 6133524
[TBL] [Abstract][Full Text] [Related]
18. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.
Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF
Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of human activated protein C. 2nd communication: tissue distribution study of a lyophilized purified human activated protein C after single or repeated intravenous administration in male mice and placental transfer and milk passage study after intravenous administration in pregnant and lactating mice.
Ishii S; Mochizuki T; Nagao T; Kudo S; Fujita A; Taniguchi K; Kondo S; Kiyoki M
Arzneimittelforschung; 1995 May; 45(5):644-56. PubMed ID: 7612069
[TBL] [Abstract][Full Text] [Related]
20. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
